You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endocrine Gland Neoplasms

Showing 26 - 50 of 8,878
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)

Completed
  • Carcinoma
  • +12 more
  • Ocoxin-Viusid
  • Havana, Cuba
    National Institute of Oncology and Radiobiology (INOR)
Jul 5, 2022

Adrenal and Other Endocrine Tumors in Patients With Sudden Death

Recruiting
  • Primary Aldosteronism
  • +3 more
  • Adrenal aldosterone synthase (CYP11B2) staining
  • +2 more
  • Helsinki, Finland
    Endocrinology, Helsinki University Hospital and University of He
Jul 8, 2022

TEXTBOOK OUTCOME IN ADRENAL NEOPLASMS

Completed
  • Outcome Assessment
  • Adrenal Neoplasm
  • Adrenalectomy
  • Alicante, Spain
    Juan Jesús Rubio García
May 24, 2023

Repository for Related Biological Studies

Recruiting
  • Sarcoma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)

    Completed
    • Neoplasms
    • +13 more
    • San Antonio, Texas
      The START Center for Cancer Care
    Jan 24, 2022

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Establishment of a Tumor Bank for Tissue Samples

    Recruiting
    • Ovarian Neoplasms
    • +5 more
    • Tumor tissue collection
    • +6 more
    • Vienna, Austria
    • +2 more
    Aug 30, 2021

    Routine Transcervical Thymectomy in MEN-1 Patients

    Completed
    • Multiple Endocrine Neoplasia Type 1 (MEN-1)
    • Thymic Carcinoid
    • Routine thymectomy, which has been performed
    • Singapore, Singapore
      National University Hospital
    Sep 25, 2021

    Pituitary Tumours: Prevalence of Associated Neoplasia

    Recruiting
    • Pituitary Tumor
    • +4 more
    • Registration of familial forms and associated neoplasia
    • Pozzilli, IS, Italy
      Neuromed
    Aug 31, 2021

    Establishment of a Tumor Bank for Blood Samples

    Recruiting
    • Ovarian Neoplasms
    • +5 more
    • Blood collection
    • Innsbruck, Austria
    • +5 more
    Aug 30, 2021

    Neuroendocrine Tumor, Anaplastic Thyroid Cancer, Adenocarcinoma Trial in Spain (Cabozantinib 40 mg)

    Recruiting
    • Neuroendocrine Tumor
    • +4 more
    • Cabozantinib 40 mg
    • Badalona, Barcelona, Spain
    • +14 more
    Feb 15, 2022

    Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism, Adrenal Tumors Trial in Singapore

    Recruiting
    • Primary Aldosteronism Due to Aldosterone Producing Adenoma
    • +2 more
    • 11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre
    • Singapore, Singapore
    • +6 more
    Oct 26, 2023

    Well Differentiated Pancreatic Endocrine Tumor Trial in Milano (Everolimus plus Octreotide LAR plus Metformin)

    Active, not recruiting
    • Well Differentiated Pancreatic Endocrine Tumor
    • Everolimus plus Octreotide LAR plus Metformin
    • Milano, Italy
      Fondazione IRCCS Istituto Tumori Milano
    Sep 3, 2021

    Pituitary Adenoma, Pituitary Tumor, Diabetes Insipidus Cranial Type Trial in Leiden (Micro-electrode measurement)

    Recruiting
    • Pituitary Adenoma
    • +3 more
    • Micro-electrode measurement
    • Leiden, Netherlands
      Leiden University Medical Center
    Apr 13, 2022

    Familial Investigations of Childhood Cancer Predisposition

    Recruiting
    • Acute Leukemia
    • +45 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      May 11, 2022

      Neuroendocrine Tumors, Intestinal Well Differentiated Endocrine Tumor, Progressive Disease Trial in France (Lutathera)

      Recruiting
      • Neuroendocrine Tumors
      • +2 more
      • Angers, France
      • +21 more
      Aug 2, 2022

      Neuroendocrine Tumors Trial in Montréal (68Ga-DOTATATE PET/CT)

      Enrolling by invitation
      • Neuroendocrine Tumors
      • 68Ga-DOTATATE PET/CT
      • Montréal, Quebec, Canada
        Jewish General Hospital
      Feb 8, 2021

      Psychosocial Aspects of Multiple Endocrine Neoplasia Syndromes

      Completed
      • Multiple Endocrine Neoplasia
      • Questionnaire
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Nov 17, 2020

      Differentiated Thyroid Gland Carcinoma, Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma Trial in Houston

      Active, not recruiting
      • Differentiated Thyroid Gland Carcinoma
      • +3 more
      • Computed Tomography
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 17, 2022

      Spanish Series of Patients Treated With Radionuclide Lutetium177

      Recruiting
      • Neuroendocrine Tumors
      • +17 more
      • Lutetium [177Lu] oxodotreotide/dotatate
      • Santiago De Compostela, A Coruña, Spain
      • +18 more
      Jul 1, 2021

      Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B Trial run by the NCI

      Completed
      Has Results
      • Medullary Thyroid Carcinoma
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Dec 1, 2020

      Ovarian Tumors, Fallopian Tube Tumors, Endocrine Gland Tumors Trial in Nanjing (Niraparib, Bevacizumab)

      Unknown status
      • Ovarian Neoplasms
      • +23 more
      • Nanjing, Jiangsu, China
        JiangSu Cancer Hospital
      Nov 8, 2020

      RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

      Active, not recruiting
      • RET-altered Non Small Cell Lung Cancer
      • +39 more
      • pralsetinib (BLU-667)
      • Phoenix, Arizona
      • +65 more
      Nov 10, 2022

      Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Tumor Trial in Houston

      Recruiting
      • Recurrent Cutaneous Melanoma
      • +27 more
      • Cord Blood-derived Expanded Allogeneic Natural Killer Cells
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Apr 28, 2021

      Meningioma, Metastatic Well Differentiated Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston (Computed

      Terminated
      • Meningioma
      • +5 more
      • Computed Tomography
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 11, 2021